# Multidisciplinary Approaches to Tumor Immunology

> **NIH NIH T32** · ROSWELL PARK CANCER INSTITUTE CORP · 2024 · $143,799

## Abstract

PROJECT SUMMARY/ABSTRACT
The overarching goals of the Tumor Immunology Training Program (TITP) at Roswell Park Comprehensive
Cancer Center Graduate Division are to educate, train, and prepare talented pre-doctoral trainees for a
profession in cancer immunology research. Driven by significant advances in understanding how the immune
system can be weaponized against cancer, future leaders in tumor immunology will not only be well-trained in
the discipline, but also will have a strong appreciation of the potential translational impact to human cancer
biology and therapy. The unique, cancer-focus of the TITP introduces trainees to an advanced didactic and
conceptual cancer immunology educational paradigm that encapsulates knowledge spanning the continuum of
basic science to clinical application. The uniqueness of this TITP is further enhanced by the integration of an
academic environment comprised of diverse faculty concentrated within a prestigious NCI-designated
Comprehensive Cancer Center. Throughout the program, trainees are continually exposed to a
comprehensive portfolio of themes and concepts in tumor immunology, responsible conduct of research, and
the principles of rigor and reproducibility. Trainees conduct their doctoral research with TITP mentors with
expertise in basic, translational, and clinical tumor immunology. The primary mission of the TITP is to support
competitively selected trainees during their third and fourth years of study. The funds requested cover
stipends and tuition for 4 pre-doctoral trainees per year. This funding is crucial to continue the upward
trajectory experienced for nearly 20 years of NRSA support in the quality and diversity of pre-doctoral trainees
focused on complex and challenging immunologic questions in cancer. NRSA-supported trainees are
prepared for a competitive biomedical career through didactic lectures and concept-driven learning in tumor
immunology and biology, grant writing, responsible conduct of research, and rigor and reproducibility. After
trainees complete all formal course work and pass a qualifying exam, degree conferral is dependent upon
fulfilling a first-authored publication requirement and passing the dissertation defense reflecting the novel and
original findings of the trainee’s body-of-work. Trainees who complete this TITP will be well-versed in all major
facets of tumor immunology and will have the solid foundation upon which to build cancer-focused careers,
guided by a clear vision of its impact on human cancer biology and treatment.

## Key facts

- **NIH application ID:** 10884414
- **Project number:** 5T32CA085183-22
- **Recipient organization:** ROSWELL PARK CANCER INSTITUTE CORP
- **Principal Investigator:** Scott I. Abrams
- **Activity code:** T32 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $143,799
- **Award type:** 5
- **Project period:** 2001-07-01 → 2028-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10884414

## Citation

> US National Institutes of Health, RePORTER application 10884414, Multidisciplinary Approaches to Tumor Immunology (5T32CA085183-22). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10884414. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*